EP3448391

MEÐFERÐARAÐFERÐIR VIÐ SJÚKDÓMUM ÞAR SEM IL-13-VIRKNI ER SKAÐLEG, MEÐ NOTKUN Á MÓTEFNUM GEGN IL-13

  • :
    EP einkaleyfi í gildi á Íslandi
  • :
    27.4.2017
  • :
    29.5.2024
  • :
    17790401.8
  • :
    24.6.2024
  • :
    15.7.2024
  • :
    26.4.2037
  • :
    26.4.2026
  • :
    30.4.2026
  • :
    METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

27.4.2017
29.5.2024
24.6.2024
15.7.2024
26.4.2026
  • :
    AbbVie Manufacturing Management Unlimited Company
  • :
    70 Sir John Rogerson's Quay, Dublin, 2, IE
  • :
    TIMONY, Gregg
  • :
    Carlsbad, CA 92009, US
  • :
    GUJRATHI, Sheila
  • :
    Rancho Santa Fe, CA 92067, US
  • :
    PEACH, Robert
  • :
    San Diego, CA 92103, US
  • :
    OLSON, Allan
  • :
    San Diego, CA 92121, US
  • :
    G.H. Sigurgeirsson ehf.
  • :
    Borgartúni 26, 105, Reykjavík,
  • :
    201662328539 P
  • :
    27.4.2016
  • :
    US
  • :
    US2017029768
  • :
    27.4.2017
  • :
    A61K 31/56, A61K 39/395, A61K 45/06, C07K 16/24

: 9

: 18.3.2025

: 26.4.2026

: Árnason Faktor ehf.